Answers are grounded in this paper and cite their sources.
Distal-less homeobox 1 (DLX1) has emerged as a promising urinary biomarker for prostate cancer. This study developed a label-free piezoelectric acoustic biosensor for selective DLX1 detection using a quartz crystal microbalance (QCM). The QCM gold electrode was sequentially functionalized with L-cysteine, graphene oxide (GO), and an amine-terminated DLX1 capture probe covalently immobilized through EDC–NHS-mediated amide bond formation. Stepwise surface functionalization was characterized by X-ray photoelectron spectroscopy (XPS), supported by contact angle measurements, X-ray diffraction, and field-emission scanning electron microscopy. XPS provided multi-element evidence for Au–S thiolate formation, GO deposition, amide coupling, probe immobilization, and Watson–Crick hybridization with the synthetic DLX1 target. Under optimized conditions, the biosensor exhibited a linear response to DLX1 concentrations and achieved a limit of detection of 81.19 nM. Non-complementary sequences, including PCA3 and SARS-CoV-2, produced frequency shifts below 9 Hz, confirming high selectivity. Comparative experiments showed that GO-mediated covalent immobilization was essential for reliable detection, whereas direct DNA attachment to bare Au generated anomalous positive frequency shifts, which were attributed to weak physisorption. The proposed platform offers a sensitive and selective strategy for quantitative DLX1 detection and may support future point-of-care nucleic acid diagnostics.
No takes yet. Share an insight, caveat, or question.
Sonklin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: